Business · 08/07/1999
FDA to Review and Revise Guidance Documents for Generic Drug Products
The FDA is seeking public input on its plans to review and revise existing guidance documents related to generic drug development, with the goal of creating more current and effective guidance for the industry.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →